Palmitic and Linoleic Acids Impair Endothelial Progenitor Cells by Inhibition of Akt/eNOS Pathway

Archives of Medical Research

Volumn 39, Issue 4, 2008, Pages 434-442

  Guo, Wei Xin ^a   Yang, Qi Dong ^a   Liu, Yun Hai ^a   Xie, Xiao Yun ^a   Wang Miao, ^a   Niu, Rui Chao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Endothelial progenitor cells; Linoleic acid; Nitric oxide; Nitric oxide synthase; Palmitic acid

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LINOLEIC ACID; N(G) NITROARGININE METHYL ESTER; PALMITIC ACID; PROTEIN KINASE B;

ARTICLE; CELL ADHESION; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; DIABETES MELLITUS; DOSE RESPONSE; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; NORMAL HUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STEM CELL;

CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; HUMANS; LINOLEIC ACIDS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PALMITIC ACID; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 41049108669     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2008.02.001     Document Type: Article

References (30)

1. Asahara T.H., Masuda T., Takahashi C., Kalka C., Pastore M., Silver, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85 (1999) 221-228
2. Murayama T., Tepper O.M., Silver M., Ma H., Losordo D.W., Isner J.M., et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol 30 (2002) 967-972
3. Hristov M., Erl W., and Weber P.C. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 23 (2003) 1185-1189
4. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5 (1999) 434-438
5. Takamiya M., Okigaki M., Jin D., Takai S., Nozawa Y., Adachi Y., et al. Granulocyte colony-stimulating factor-mobilized circulating c-Kit+/Flk-1+ progenitor cells regenerate endothelium and inhibit neointimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol 26 (2006) 751-757
6. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89 (2001) E1-E7
7. Loomans C.J., de Koning E.J., Staal F.J., Rookmaaker M.B., Verseyden C., de Boer H.C., et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53 (2004) 195-199
8. Tepper O.M., Galiano R.D., Capla J.M., Kalka C., Gagne P.J., Jacobowitz G.R., et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106 (2002) 2781-2786
9. Kang L.N., Xu B., Chen Q., Gao L., Yao K., and Shi G.F. Ischemia-induced bone marrow-derived endothelial progenitor cells mobilization impairment in diabetic mice. Zhonghua Xin Xue Guan Bing Za Zhi 35 (2007) 513-516
10. Kusuyama T., Omura T., Nishiya D., Enomoto S., Matsumoto R., Takeuchi K., et al. Effects of treatment for diabetes mellitus on circulating vascular progenitor cells. J Pharmacol Sci 102 (2006) 96-102
11. Shulman G.I. Cellular mechanisms of insulin resistance. J Clin Invest 106 (2000) 171-176
12. Steinberg H.O., Tarshoby M., Monestel R., Hook G., Cronin J., Johnson A., et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 100 (1997) 1230-1239
13. Steinberg H.O., Paradisi G., Hook G., Crowder K., Cronin J., and Baron A.D. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes 49 (2000) 1231-1238
14. Carlsson M., Wessman Y., Almgren P., and Groop L. High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease. Arterioscler Thromb Vasc Biol 20 (2000) 1588-1594
15. Jouven X., Charles M.A., Desnos M., and Ducimetiere P. Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation 104 (2001) 756-761
16. Asahara T.T., Takahashi H., Masuda C., Kalka D., Chen H., Iwaguro, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18 (1999) 3964-3972
17. Llevadot J., Murasawa S., Kureishi Y., Uchida S., Masuda H., Kawamoto A., et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 108 (2001) 399-405
18. Ma F.X., and Han Z.C. Akt signaling and its role in postnatal neovascularization. Histol Histopathol 20 (2005) 275-281
19. Fulton D.J.P., Gratton T.J., McCabe J., Fontana Y., Fujio K., Walsh, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase. Akt Nature 399 (1999) 597-601
20. Svedberg J., Bjorntorp P., Smith U., and Lonnroth P. Free fatty acid inhibition of insulin binding, aggregation, and action in isolated rat adipocytes. Diabetes 39 (1990) 570-574
21. Nims R.W., Cook J.C., Krishna M.C., Christodoulou D., Poore C.M., Miles A.M., et al. Colorimetric assays for nitric oxide and nitrogen oxide species formed from nitric oxide stock solutions and donor compounds. Methods Enzymol 268 (1996) 93-105
22. Ma F.X., Zhou B., Chen Z., Ren Q., Lu S.H., Sawamora T., et al. Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J Lipid Res 47 (2006) 1227-1237
23. Aicher A., Heeschen C., Mildner-Rihm C., Urbich C., Ihling C., Technau-Ihling K., Zeiher A.M., et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9 (2003) 1370-1376
24. Zanetti M., Barazzoni R., Stebel M., Roder E., Biolo G., Baralle F.E., Cattin L., et al. Dysregulation of the endothelial nitric oxide synthase-soluble guanylate cyclase pathway is normalized by insulin in the aorta of diabetic rat. Atherosclerosis 181 (2005) 69-73
25. Steinberg H.O., and Baron A.D. Vascular function, insulin resistance and fatty acids. Diabetologia 45 (2002) 623-634
26. Montagnani M., Chen H., Barr V.A., and Quon M.J. Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser (1179). J Biol Chem 276 (2001) 30392-30398
27. Zeng G., and Quon M.J. Insulin-stimulated production of nitric oxide is inhibited by wortmannin: direct measurement in vascular endothelial cells. J Clin Invest 98 (1996) 894-898
28. Zeng G., Nystrom F.H., Ravichandran L.V., Cong L.N., Kirby M., Mostowski H., et al. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide inhuman vascular endothelial cells. Circulation 101 (2000) 1539-1545
29. Montagnani M., Ravichandran L.V., Chen H., Esposito D.L., and Quon M.J. Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells. Mol Endocrinol 16 (2002) 1931-1942
30. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., and Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399 (1999) 601-605